Donaldson Capital Management’s GSK GSK Stock Holding History

Donaldson Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$434K	Buy	+8,278	New	+$438K	0.01%	228
2017 Q1	–	Sell	-4,504	Closed	-$217K	–	158
2016 Q4	$217K	Sell	4,504 -454	-9%	-$22.4K	0.03%	144
2016 Q3	$267K	Buy	+4,958	New	+$272K	0.04%	126
2014 Q4	–	Sell	-5,942	Closed	-$341K	–	153
2014 Q3	$341K	Buy	5,942 +946	+19%	+$58K	0.05%	101
2014 Q2	$334K	Sell	4,996 -40	-0.8%	-$2.71K	0.05%	101
2014 Q1	$336K	Hold	5,036	–	–	0.06%	87
2013 Q4	$336K	Buy	5,036 +320	+7%	+$20.7K	0.06%	81
2013 Q3	$296K	Hold	4,716	–	–	0.06%	81
2013 Q2	$295K	Buy	+4,716	New	+$299K	0.07%	74

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Donaldson Capital Management's GSK Position: Q2 2026 in Review

Donaldson Capital Management opened a new position in GSK (GSK) in Q2 2026: 8,278 shares worth $434K. The stake represents 0.01% of the portfolio and ranks #228 among its holdings. This is a return to the name: Donaldson Capital Management previously reported a position in GSK as recently as Q4 2016.

Donaldson Capital Management first reported a position in GSK in Q2 2013 and has held it in 9 quarters since. 1,042 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Donaldson Capital Management held 8,278 shares of GSK worth $434K as of Q2 2026.
GSK was a new Donaldson Capital Management position in Q2 2026.
GSK made up 0.01% of Donaldson Capital Management's portfolio in Q2 2026, its #228 holding.
Donaldson Capital Management first reported a position in GSK in Q2 2013 and has held it in 9 quarters since.
1,042 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Donaldson Capital Management's 13F filing for Q2 2026, filed 5 Aug 2026.